Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.90 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL3870317 | 1.00 | SLC34A1 (0.90) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28145798 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28704385 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL3666220 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL2324800 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL4332135 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL532270 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28486535 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL5608739 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL3972151 | 0.95 | SLC34A1 (0.80) | SLC34A1LMNAKDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 788 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4563638-A1 | RUBBER FILLER, RUBBER COMPOSITE MATERIAL CONTAINING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF | PetroChina Company Limited (CN) | 2025-06-04 | — | — | EP | claimed |
| CN-118267451-A | Nasal cavity cleaning spray based on virus blocking agent and application thereof | 康码（上海）生物科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-111153993-B | Preparation method of anti-TNF-alpha monoclonal antibody | 正大天晴药业集团南京顺欣制药有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-113049563-B | Method for detecting formaldehyde in air and food based on manganese dioxide nano-sheet | 湖南师范大学 | 2024-06-25 | — | — | CN | claimed |
| CN-114920667-B | Electrochemical preparation method of atta Lu Lunzhi | 湖南大学 | 2024-06-21 | — | — | CN | claimed |
| CN-114557955-B | Pharmaceutical composition, preparation method and application thereof | 沈阳兴齐眼药股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118185892-A | Short-chain dehydrogenase and application thereof in synthesis of (R) -tetrahydrothiophene-3-alcohol | 河北工业大学 | 2024-06-14 | — | — | CN | claimed |
| CN-117582333-B | Hot compress pack containing volcanic rock and preparation method thereof | 天津蓝美生物科技开发有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118028259-A | Short-chain dehydrogenase and application thereof | 河北工业大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117903033-A | Synthesis method of taxane side chain intermediate | 上海卓鼎生物技术有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-101912372-A | Nilvadipine liposome tablets | HAINAN SHUER PHARMACEUTICAL RES CO LTD | 2010-12-15 | — | — | CN | claimed |
| CN-101822640-A | Sulbenicillin sodium liposome injection | MING WANG | 2010-09-08 | — | — | CN | claimed |
| CN-101804051-A | Liposome injection of pharmaceutical composition of amoxicillin sodium and clavulanate potassium | HAINAN MEILANSHIKE PHARMA CO | 2010-08-18 | — | — | CN | claimed |
| CN-101780128-A | Preparation method of brown ginseng | HONG HUO | 2010-07-21 | — | — | CN | claimed |
| CN-101601655-A | Maleic acid cinepazide liposome injection and new application the thereof | MING WANG (CN) | 2009-12-16 | — | — | CN | claimed |
| CN-1989966-A | Pharmaceutical composition comprising rifamoin and isoniazid | CHONGQING HUABANG PHARMACY LTD (CN) | 2007-07-04 | — | — | CN | claimed |
| CN-1654628-A | Process for changing intact phycobilisome of spirulina platensis | UNIV SHANDONG (CN) | 2005-08-17 | — | — | CN | claimed |
| CN-1164271-C | Stable xylometazoline and oxymetazoline solutions | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-09-01 | — | — | CN | claimed |
| CN-1361689-A | Stable xylometazoline and oxymetazoline solutions | BOEHRINGER INGELHEIM INT (DE) | 2002-07-31 | — | — | CN | claimed |
| US-4290910-A | CONTROLLING PH, AMINE, BUFFER | TANABE SEIYAKU CO., LTD. (JP) | 1981-09-22 | — | — | US | claimed |